| Dr Jeremy D Gradon, MD | |
|
2435 W Belvedere Ave, Suite 17, Baltimore, MD 21215-5224 | |
| (410) 601-5941 | |
| (410) 601-6006 |
| Full Name | Dr Jeremy D Gradon |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 40 Years |
| Location | 2435 W Belvedere Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124078340 | NPI | - | NPPES |
| 440000509 | Other | MD | R/R MEDICARE PROVIDER # |
| CC3778 | Other | MD | R/R MEDICARE GROUP # |
| 182401500 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | D42061 (Maryland) | Primary |
| 207R00000X | Internal Medicine | D42061 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
| Levindale Hebrew Geriatric Center And Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sinai Hospital Of Baltimore, Inc | 0941112346 | 333 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
With a $4.6 million grant from the National Institutes of Health (under the Bioengineering Research Partnership program), research led by Rensselaer Polytechnic Institute will make its important final steps toward the development of a safer, synthetic alternative to current heparin. The researchers believe that kilogram quantities of the new drug could be developed in under five years.
The University of Twente carried out the first study worldwide that shows patients with COPD (lung disease caused by smoking) and other illnesses (heart disease, diabetes, anxiety and depression) have better outcomes if they follow a self-management program with a customized action plan. Anke Lenferink of UT recently obtained a doctoral degree on this subject.
› Verified 9 days ago
| Entity Name | Sinai Hospital Of Baltimore, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043235666 PECOS PAC ID: 0941112346 Enrollment ID: O20031104000353 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
With a $4.6 million grant from the National Institutes of Health (under the Bioengineering Research Partnership program), research led by Rensselaer Polytechnic Institute will make its important final steps toward the development of a safer, synthetic alternative to current heparin. The researchers believe that kilogram quantities of the new drug could be developed in under five years.
The University of Twente carried out the first study worldwide that shows patients with COPD (lung disease caused by smoking) and other illnesses (heart disease, diabetes, anxiety and depression) have better outcomes if they follow a self-management program with a customized action plan. Anke Lenferink of UT recently obtained a doctoral degree on this subject.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeremy D Gradon, MD 2401 W Belvedere Ave, Attn: Credentialing, Baltimore, MD 21215-5216 Ph: (410) 601-5524 | Dr Jeremy D Gradon, MD 2435 W Belvedere Ave, Suite 17, Baltimore, MD 21215-5224 Ph: (410) 601-5941 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
With a $4.6 million grant from the National Institutes of Health (under the Bioengineering Research Partnership program), research led by Rensselaer Polytechnic Institute will make its important final steps toward the development of a safer, synthetic alternative to current heparin. The researchers believe that kilogram quantities of the new drug could be developed in under five years.
The University of Twente carried out the first study worldwide that shows patients with COPD (lung disease caused by smoking) and other illnesses (heart disease, diabetes, anxiety and depression) have better outcomes if they follow a self-management program with a customized action plan. Anke Lenferink of UT recently obtained a doctoral degree on this subject.
› Verified 9 days ago
Dr. Leonard Anang Sowah, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |